Amgen Inc. (NASDAQ:AMGN) [Trend Analysis] retains strong position in active trade, as shares scoring 0.46% to $166.80 in active trade session, while looking at the shares volume, around 246976 shares have changed hands in this session. Amgen (AMGN) reported that European Commission (EC) has granted marketing authorization for AMGEVITA in all …
March, 2017
-
24 March
Stocks Rallying on Profitability Valuation: Amgen (NASDAQ:AMGN), Edwards Lifesciences (NYSE:EW)
Amgen Inc. (NASDAQ:AMGN) presented as an active mover, shares inching up -0.84% to traded at $166.04 in most recent trading session. The firm has floated short ratio of 1.19%, hold to candle to sentiment indicator of Short Ratio, its stand at 2.24. Efficiency or profitability analysis gives an appropriate idea …
-
21 March
Active Broker’s Concerns In Focus: Gilead Sciences (NASDAQ:GILD), Amgen Inc. (NASDAQ:AMGN)
Gilead Sciences, Inc. (NASDAQ:GILD) [Trend Analysis] knocking active thrust in leading trading session, shares a loss of -0.51% to 68.71 with around 6.2 Million shares have changed hands in this session. Gilead Sciences Canada, Inc. (GILD) commends the continued leadership of Quebec in the treatment of hepatitis C with the listing …
-
20 March
Active Broker’s Choice in Focus: Tiffany & Co. (NYSE:TIF), Amgen Inc. (NASDAQ:AMGN)
Tiffany & Co. (NYSE:TIF) [Trend Analysis] knocking active thrust in leading trading session, shares an advance of 2.71% to 92.42 with around 6.26 Million shares have changed hands in this session. Tiffany & Co. (TIF) rose the most in more than two months as new stores in Asia and higher-priced jewelry …
-
20 March
Analysts Buzzer on Considerable Stocks Figures: Amgen Inc. (NASDAQ:AMGN)
In active leading trade session, Amgen Inc. (NASDAQ:AMGN) knocking down -6.38% to trade at $168.61. The firm receives analyst recommendation of 2.30 on scale of 1-5 with week’s performance of -7.07%. Experts’ Critical Views Finally, analysts shed their light over the AMGN price targets; maintaining price high target of 212 …
-
17 March
Stocks Shining Bright on Wall Street: Amgen Inc. (NASDAQ:AMGN), Immune Pharmaceuticals (NASDAQ:IMNP)
Amgen Inc. (NASDAQ:AMGN) also run on active notice, stock price reduced -1.36% after traded at $180.11 in most recent trading session. AMGN has price to earnings ratio of 17.55 and the price to current year EPS stands at 13.10%. Whereas the traders who further want to see about this, may …
-
15 March
Vigorous Gainers/Losers Roundup: AGNC Investment (NASDAQ:AGNC), Amgen (NASDAQ:AMGN)
AGNC Investment Corp. (NASDAQ:AGNC) [Trend Analysis] luring active investment momentum, shares an advance 0.76% to $19.27. AGNC Investment Corp. (AGNC) reported that its Board of Directors has declared a cash dividend of $0.18 per share of common stock for March 2017. The dividend is payable on April 7, 2017 to common …
-
14 March
Amgen Inc. (NASDAQ:AMGN) and Boeing (NYSE:BA); Unusual Stocks Mover Hurt By Street Views
Amgen Inc. (NASDAQ:AMGN) [Trend Analysis] retains strong position in active trade, as shares scoring -0.21% to $181.05 in active trade session, while looking at the shares volume, around 2.53 Million shares have changed hands in this session. Amgen Inc. (AMGN) declared that its pricey cholesterol drug Repatha importantly reduced patients’ need …
-
14 March
Eye Catching Active Stocks: Amgen Inc. (NASDAQ:AMGN), Innocoll Holdings (NASDAQ:INNL)
Shares of Amgen Inc. (NASDAQ:AMGN) [Trend Analysis] runs in leading trade, it plunging -0.21% to traded at $181.05. The firm has price volatility of 1.18% for a week and 1.45% for a month. Its beta stands at 1.25 times. Amgen (AMGN) revealed that a Phase 3 study evaluating Repatha (evolocumab) in patients …
-
7 March
Stocks Faring Away From Broker’s Choice: Amgen (NASDAQ:AMGN), Anthem (NYSE:ANTM)
Amgen Inc. (NASDAQ:AMGN) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it -0.41% to close at $179.46 with the total traded volume of 3.27 Million shares. The AMGN held a rough session during the week but was ready to get some critical analysis. The stock was …